Corbus Pharmaceuticals Holdings Inc. Stock Rises 4.0%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Corbus Pharmaceuticals Holdings Inc. rose 4.0% to $10.49 on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 0.3% to 26,644.91 and Dow Jones Industrial Average falling 0.5% to 53,459.78.

This was the stock's fifth consecutive day of gains.

Corbus Pharmaceuticals Holdings Inc. closed 49.0% short of its 52-week high of $20.56, which the company achieved on October 20th.

The stock outperformed some of its peers, as Vanda Pharmaceuticals Inc. rose 0.8% to $5.26, Fortress Biotech Inc. fell 3.8% to $2.82, and Viking Therapeutics Inc. rose 1.33% to $33.63.

Trading volume totaled 869,122, compared to the 50-day average of 382,460.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

August 17, 2026 16:35 ET (20:35 GMT)